Engineered immune cells battle acute leukaemia

  title={Engineered immune cells battle acute leukaemia},
  author={Heidi Ledford},
Modified T cells seek out and destroy blood cancer. 

Topics from this paper


CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
The results demonstrate the marked antitumor efficacy of 19-28z CAR-modified T cells in patients with relapsed/refractory B-ALL and the reliability of this therapy to induce profound molecular remissions, forming a highly effective bridge to potentially curative therapy with subsequent allo-HSCT. Expand